NM_000386.4:c.1217-4834C>G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000386.4(BLMH):c.1217-4834C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0841 in 152,166 control chromosomes in the GnomAD database, including 832 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.084 ( 832 hom., cov: 32)
Consequence
BLMH
NM_000386.4 intron
NM_000386.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 2.20
Publications
0 publications found
Genes affected
BLMH (HGNC:1059): (bleomycin hydrolase) Bleomycin hydrolase (BMH) is a cytoplasmic cysteine peptidase that is highly conserved through evolution; however, the only known activity of the enzyme is metabolic inactivation of the glycopeptide bleomycin (BLM), an essential component of combination chemotherapy regimens for cancer. The protein contains the signature active site residues of the cysteine protease papain superfamily. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.166 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| BLMH | ENST00000261714.11 | c.1217-4834C>G | intron_variant | Intron 11 of 11 | 1 | NM_000386.4 | ENSP00000261714.6 | |||
| ENSG00000266120 | ENST00000577420.2 | n.428+1760G>C | intron_variant | Intron 2 of 2 | 3 | |||||
| BLMH | ENST00000578090.5 | n.*891-4834C>G | intron_variant | Intron 10 of 10 | 2 | ENSP00000462353.1 |
Frequencies
GnomAD3 genomes AF: 0.0841 AC: 12785AN: 152046Hom.: 831 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
12785
AN:
152046
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0841 AC: 12803AN: 152166Hom.: 832 Cov.: 32 AF XY: 0.0831 AC XY: 6179AN XY: 74390 show subpopulations
GnomAD4 genome
AF:
AC:
12803
AN:
152166
Hom.:
Cov.:
32
AF XY:
AC XY:
6179
AN XY:
74390
show subpopulations
African (AFR)
AF:
AC:
7020
AN:
41504
American (AMR)
AF:
AC:
804
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
292
AN:
3470
East Asian (EAS)
AF:
AC:
231
AN:
5186
South Asian (SAS)
AF:
AC:
462
AN:
4818
European-Finnish (FIN)
AF:
AC:
468
AN:
10592
Middle Eastern (MID)
AF:
AC:
27
AN:
294
European-Non Finnish (NFE)
AF:
AC:
3323
AN:
67986
Other (OTH)
AF:
AC:
173
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
592
1183
1775
2366
2958
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
142
284
426
568
710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
277
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.